High expressions of GALNT5 and GALNT10 are positively correlated with pancreatic cancer survival, while expressions of GALNT8 AND GALNT10 are negatively correlated with survival in PAAD (pancreatic adenocarcinoma). Here, GALNT5 is linked to familial pancreatic carcinoma.